The latest funding round of the New York Fund for Innovation in Research and Scientific Talent (NYFIRST) includes a $10 million increase to the program.
Administered by Empire State Development, the program provides grants to medical schools to attract and retain translational research scientists in New York, with the broader aim of cultivating biotech startups and fostering sustained economic growth through high-skill job creation and commercial opportunities.
The program provides up to $1 million in funding to cover costs related to each investigator’s research.
Applications for the sixth round of the program will run a full 12 months with rolling reviews, allowing medical schools to submit applications from now until April 30, 2026. More information can be found here.
“Our NYFIRST program has emerged as a transformative force for scientific advancement, turning New York’s medical institutions into powerhouses that attract the brightest minds in research,” Gov. Kathy Hochul said.
Launched in 2018 with an initial funding of $15 million, the FY25 Enacted Budget appropriated an additional $10 million for NYFIRST recognizing its potential to drive life science economic development across the state.
[email protected] / (585) 653-4021
d